WeVote
Log In

Bill

Bill

HB 379

Screening and approval program for retail sale of products containing certain substances; establish.

2026 Regular Session Introduced by Jay McKnight

Mississippi HB 379 creates a mandatory screening and approval program for retail products containing unspecified substances before market sale.

Referred To Public Health and Human Services
#publichealthandhumanservices
0
WeVote Research Nonpartisan
Bill Summary · HB 379

Legislative bill overview

HB 379 establishes a screening and approval program for retail products containing certain unspecified substances in Mississippi. The bill creates a regulatory mechanism requiring products to undergo review before being sold to consumers. The specific substances subject to this program are not detailed in the available bill information.

Why is this important

This bill represents a shift toward pre-market regulatory oversight of consumer products, which could affect product availability, pricing, and business operations. The practical impact depends entirely on which substances are designated for screening—this could range from minor regulatory burden to significant market disruption depending on legislative intent.

Potential points of contention

  • Lack of specificity: The bill references "certain substances" without clarification, making it unclear what products would be affected and raising concerns about regulatory scope creep
  • Business impact: Retail businesses may face increased compliance costs, longer product approval timelines, and potential inventory delays depending on the screening process requirements
  • Consumer access: Pre-market approval programs can delay availability of products consumers want, or restrict access to items deemed problematic by regulators

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.